Khandwala Hasnain M
Division of Endocrinology, University of Saskatchewan, Saskatoon, SK, Canada.
South Med J. 2006 Nov;99(11):1282-4. doi: 10.1097/01.smj.0000232973.76521.5d.
A significant number of patients with hyperprolactinemia have macroprolactinemia, a condition characterized by the preponderance of big-big prolactin with normal levels of free prolactin. As macroprolactin does not have biologic activity, such patients do not require further investigations or treatment for hyperprolactinemia. The case of a patient with hyperprolactinemia diagnosed during investigation of secondary infertility is presented. She was treated for over 2 years with dopamine agonists, with which her prolactin level normalized, but she remained infertile. Subsequent investigations demonstrated that she suffered from macroprolactinemia, not true hyperprolactinemia. The patient is currently not on dopamine agonist therapy, and although her total prolactin levels remain significantly elevated, her free prolactin levels have been in the normal range. Physicians should familiarize themselves with this entity and consider testing for it in patients with hyperprolactinemia to avoid an inappropriate diagnosis and unnecessary treatment.
相当一部分高催乳素血症患者患有巨催乳素血症,该病症的特征是大分子催乳素占优势而游离催乳素水平正常。由于巨催乳素没有生物活性,此类患者无需针对高催乳素血症进行进一步检查或治疗。本文介绍了一例在继发性不孕检查期间诊断出高催乳素血症的患者。她接受了2年多的多巴胺激动剂治疗,催乳素水平恢复正常,但仍未受孕。后续检查表明她患有巨催乳素血症,而非真正的高催乳素血症。该患者目前未接受多巴胺激动剂治疗,尽管其总催乳素水平仍显著升高,但其游离催乳素水平已处于正常范围。医生应熟悉这一病症,并考虑对高催乳素血症患者进行检测,以避免不恰当的诊断和不必要的治疗。